Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients

Intensive Care Medicine, Supplement

Volumn 26, Issue 4, 2000, Pages S452-S462

  Herr, Daniel L ^a   Kelly, Kathleen ^b   Hall, Jesse Booth ^c   Ulatowski, John ^d   Fulda, Gerard James ^e   Cason, Brian ^f   Hickey, Robert ^g   Nejman, Antoni M ^h   Zaloga, Gary P ⁱ   Teres, Daniel ^j,k  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e MEDICAL CENTER OF DELAWARE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UCSF Medical Center at Parnassus   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ SUBURBAN HOSPITAL   (United States)

^j ASTRAZENECA   (United Kingdom)

^k TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Calcium; Critical illness; Disodium edetate; Homeostasis; Magnesium; Propofol

Indexed keywords

EDETIC ACID; PROPOFOL;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; FEVER; HEART ATRIUM FIBRILLATION; HUMAN; HYPERNATREMIA; HYPOCALCEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; INTENSIVE CARE; INTRAVENOUS ANESTHESIA; KIDNEY FAILURE; KIDNEY FUNCTION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINERAL BALANCE; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEDATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANESTHETICS, INTRAVENOUS; CALCIUM; CHELATING AGENTS; CONSUMER PRODUCT SAFETY; EDETIC ACID; FEMALE; HEMODYNAMIC PROCESSES; HOMEOSTASIS; HUMANS; INTENSIVE CARE UNITS; MAGNESIUM; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PRESERVATIVES, PHARMACEUTICAL; PROPOFOL; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0034524966     PISSN: 09351701     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Comparison of propofol and midazolam for sedation in intensive care unit patients
2. Infusion of propofol versus midazolam for sedation in the intensive care unit following coronary artery surgery
3. Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting
4. Comparison of propofol and midazolam for sedation in intensive care unit patients
5. The growth of microorganisms in propofol and mixtures of propofol and lidocaine
6. Microbial growth and endotoxin production in the intravenous anesthetic propofol
7. Postoperative infections traced to contamination of an intravenous anesthetic propofol
8. Severe sepsis after intravenous injection of contaminated propofol
9. Bacterial contamination of an anesthetic agent
10. Antibacterial activities of new synthetic divalent cation chelators
11. ICU sedation: A review of its pharmacology and assessment
12. Controlled sedation with alphaxalone-alphadolone
13. APACHE II: A severity of disease classification system
14. Effects of propofol containing EDTA on mineral metabolism and adverse events in medical ICU patients with pulmonary dysfunction
15. Cation metabolism with and without EDTA during propofol sedation of patients with impaired renal function
16. Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients
17. Involvement of the cervical sympathetic nervous system in the changes of calcium homeostasis during turpentine oil-induced stress in rats
18. Interaction studies and other investigations of the pharmacology of propofol ("Diprivan")
19. A review of the safety and tolerance of propofol (Diprivan)
20. The antioxidant potential of propofol (2,6-diisopropylphenol)
21. Effect of propofol on in vitro lipid peroxidation induced by different free radical generating systems - A comparison with vitamin E
22. The effect of propofol on oxidative stress in platelets from surgical patients
23. Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury
24. Pharmacological properties of propofol: Therapeutic implications
25. Propofol reduces neuronal transmission damage and attenuates the changes in calcium, potassium, and sodium during hyperthermic anoxia in rat hippocampal slice
26. Modulation of cardiac calcium channels by propofol
27. Propofol in the treatment of moderate and severe head injury: A randomized, prospective double-blinded pilot trial
28. Neuroprotection by propofol in acute mechanical injury: Role of GABAergic inhibition
29. Propofol neuroprotection in a rat model of ischemia reperfusion injury
30. Propofol protects cultured rat hippocampal neurons against N-methyl-D-aspartate receptor-mediated glutamate toxicity
31. Effect of 2,6-diisopropylphenol of the delayed hippocampal cell loss following transient forebrain ischemia in the gerbil
32. Propofol prevents peroxide-induced inhibition of glutamate transport in cultured astrocytes
33. Effect of anesthesia on the cytokine responses to abdominal surgery
34. Propofol inhibits human neutrophil functions
35. Propofol and immunomodulation: An in-vitro study
36. The effect of anaesthesia and surgery on plasma cytokine production
37. Dissertations from Scandinavia: Propofol emulsion anaesthesia and the immune response
38. Influence of dietary fatty acids on cytokine production and its clinical implications
39. Immunoregulation by parenteral lipids: Impact of the n-3 and n-6 fatty acid ratio
40. Lipid modulation and systemic inflammation
41. 2EDTA infusion. A review
42. Calcium as a mediator in septic shock
43. Calcium administration increases the mortality of endotoxic shock in rats
44. Low dose calcium administration increases mortality during septic peritonitis
45. Urinary excretion of essential metals following intravenous calcium disodium edetate: An estimate of free zinc and zinc status in man
46. Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA
47. Benefits and dangers of iron during infection
48. Transferrin and iron salts modulate differently tumor necrosis factor-alpha secretion by cultured human mononuclear cells
49. Iron, infections, and the anemia of inflammation